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Bruce I Sodowich, Daniel R Zweitzig*, Nichol M Riccardello and S Mark O’HaraAbstract
Background: Antimicrobial Susceptibility Testing (AST) is a methodology in which the sensitivity of a microorganism is
determined via its inability to proliferate in the presence of an antimicrobial agent. Results are reported as minimum
inhibitory concentrations (MICs). The present study demonstrates that measurement of DNA polymerase activity via
Enzymatic Template Generation and Amplification (ETGA) can be used as a novel means of determining the MIC of a
microbe to an antibiotic agent much sooner than the current standardized method.
Methods: Time course analysis of ETGA is presented from bacterial cultures containing antibiotic agents and compared
to the end-point results of standard macrobroth method AST.
Results: MIC determinations from ETGA results at 4, 6, and 22 hours are compared to the MICs from the standard
method and the results are shown to be in agreement. Additionally, reliable AST analysis using ETGA can be performed
on bacteria harvested directly from spiked blood cultures.
Conclusions: AST analysis with ETGA is shown to be equivalent to AST analysis using gene-specific qPCR assays against
the measured microbe. Future development of this novel method for performing AST in a clinical setting is discussed.Background
Antimicrobial Susceptibility Testing (AST) is a method
used to predict the response of a clinically isolated micro-
organism to antimicrobial agents so that the most appro-
priate therapy may be administered to a patient [1,2].
Typically, the results of AST are reported as minimum
inhibitory concentrations (MICs), which is the minimum
concentration of a particular agent that will inhibit the vis-
ible growth of a microorganism after overnight incubation
[3]. AST can be performed in several ways, via disk diffu-
sion or Kirby-Baur method [4,5], agar dilution, or broth di-
lution [6,7]. The sensitivity or resistance of an organism to
a drug is based on the interpretation of the MIC compared
to interpretive standards [8].
AST is routinely performed from positive blood cul-
tures bottles from patients where bacteremia or sepsis is* Correspondence: dzweitzig@zeusscientific.com
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reproduction in any medium, provided the orsuspected. However, traditional methods of determining
the AST profile may take up to 24 hours, and that does
not include the additional time of 24–48 hours required
for the isolation of the organism [9]. Therefore, reducing
the time to results of AST on which physicians can
make sound clinical decisions for the management of
their patients would have both a significant positive clin-
ical impact and be more cost effective [10,11]. Auto-
mated AST systems are currently available within the
clinical diagnostics market [12], and the technology used
by these platforms require bacterial isolation. However,
several reports using automated AST systems have been
published which indicate that reliable AST results can be
achieved directly from the positive blood culture or with
minimal sample preparation, which bypasses the need of
time consuming bacterial isolation, and further reducing
the time to results [13-15].
Recent literature has introduced the emerging technol-
ogy of molecular AST [16-19] in which quantitative PCR
is used to monitor the growth of bacterial cultures inral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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amplification of the rpoB gene; the 16S ribosomal locus
universally found in the bacterial genome. The technol-
ogy is based on the premise that the growth kinetics of
bacteria in culture can be monitored by measuring the
increasing amounts genomic DNA. In this fashion, MICs
may be determined on the same day as the initial inocu-
lation rather than an overnight incubation. The kinetics
of increasing PCR signal from a growing culture in the
presence of an antibiotic can be used to determine whether
a pathogen is resistant or susceptible to the agent. Further-
more, one group reports a workflow in which molecular
AST can be performed on bacteria harvested directly from
blood culture using serum separation tubes, identifying the
pathogen with species specific qPCR probes, and produ-
cing a molecular AST result in a single day [20].
Our group has previously reported a novel method-
ology termed Enzyme Template Generation and Amp-
lification (ETGA) that enables universal, sensitive and
quantitative measurement of bacterial proliferation via
measurement of endogenous DNA polymerase activity
[21]. In this report, we demonstrate that molecular AST
and MIC determination can be performed via ETGA-
mediated monitoring of DNA polymerase activity. We
compare the functionality of ETGA AST to PCR-based
molecular AST using gene-specific qPCR assays (gsPCR)
against either S. aureus or E. coli. We also show that
ETGA AST can be used to determine MICs from bacteria
harvested directly from spiked blood cultures.
Methods
Bacterial strains, cultivation, and antibiotics tested
The following strains were used in this study: Escherichia
coli ATCC 25922, methicillin susceptible Staphylococcus
aureus ATCC 29213, and methicillin resistant Staphylo-
coccus aureus NRS241. All strains were propagated on
Brain-Heart Infusion Agar (Teknova, Hollister, CA). The
S. aureus strains, both methicillin resistant and suscep-
tible, were tested for susceptibility against oxacillin and
vancomycin (Sigma Aldrich, St. Louis, MO). The E. coli
strain was tested for susceptibility against ciprofloxacin
and tetracycline (Sigma Aldrich, St. Louis, MO).
Macrodilution broth method for the determination of
antimicrobial susceptibility
The macrobroth dilution method and the interpretive
standards for determining the antimicrobial susceptibil-
ity of a microorganism to an antimicrobial agent are
published by the Clinical and Laboratory Standards In-
stitute [6,8]. In brief, an antibiotic was diluted into 2 mL
of Cation-Adjusted Mueller Hinton Broth (CA-MHB,
Teknova, Hollister, CA) at twice the concentration of
the highest level of agent that will be tested in a 14 mL
polypropylene round-bottom tube (Becton-Dickenson,Franklin Lakes, NJ). This was serially diluted in two-fold
steps (1 mL: 1 mL) to create the desired antibiotic range;
each tube containing twice the ultimate concentration of
drug in 1 mL of broth. An additional tube containing 1 mL
of broth without drug is also prepared as the growth con-
trol. For testing S. aureus, the CA-MHB was supplemented
with additional NaCl to a final concentration of 2% (w/v)
in order to enhance the methicillin resistant phenotype, if
present, when testing for susceptibility against oxacillin
[6,22]. Freshly grown colonies of the microorganism to be
tested were suspended in a 0.9% saline solution and ad-
justed to a 0.5 McFarland standard. This bacterial suspen-
sion was further diluted in CA-MHB 1:150-fold and 1 mL
of this secondary suspension was added to each broth
containing antibiotic. This produces a series of 2 mL cul-
tures containing the desired range of antibiotic in which
each culture contains approximately 5.0E + 05 CFU/mL of
bacteria. The inoculation concentration was verified by re-
moving a 0.01 mL aliquot from the growth control culture,
diluting it 1000-fold in 0.9% saline solution and directly
plating 0.1 mL for CFU enumeration. The cultures were
incubated at 35 ± 2°C, shaking at 350 rpm for 20–24 hours.
The MIC of the drug/bacteria combination is determined
as the culture containing the lowest concentration of anti-
biotic which fully inhibits the propagation of the culture
(no visual turbidity) after the incubation period.
Time course sampling of the AST cultures and ETGA
substrate conversion
The experimental design of the study is shown in Figure 1.
After inoculation of each macrodilution broth with ap-
proximately 5.0E + 05 CFU/mL of bacteria, at 0, 2, 4, 6,
and 22 hours (the overnight incubation) a 0.01 mL aliquot
was removed from each culture and diluted 1:10 in nucle-
ase free water (Life Technologies, Carlsbad, CA). If the
sample was taken from a turbid culture after 22 hours of
incubation, the sample was diluted 1:1E + 04 in nuclease
free water by serial dilution. From each diluted sample,
0.01 mL was removed and placed into a 1.5 mL screw-
capped tube containing glass beads and 0.05 mL of ETGA
reaction solution. The bead-mill tubes were subsequently
milled for bacteria lysis, incubated at 37°C for 20 minutes
followed by 95°C for 5 minutes (to terminate the reaction),
spun down, and stored at -20°C prior to analysis. At the
final time point, ETGA reagent and positive controls [21]
were performed alongside the samples.
A brief description of the mechanism of the ETGA assay
is as follows; the ETGA reaction solution bead mill tube is
formulated to facilitate microbe-derived DNA polymerase-
mediated extension of a primer-template oligonucleotide
substrate. Upon bead milling, microbe cell wall lysis allows
contact between active microbe derived DNA poly-
merases and the primer-template substrate. A successful
DNA polymerase primer-template extension event of the
Figure 1 Experimental design of the study. On day one, the macrobroth AST is assembled. At the indicated time points, an aliquot is removed
from each broth and diluted ten-fold. A portion of the diluted sample is subjected to bead milling for bacterial lysis, and incubated for ETGA
substrate conversion. Once processed, the samples are stored at -20°C prior to analysis. On day two, the MIC of the AST is determined by visual
turbidity. A final time point sample from each culture is taken and processed as day one, except the samples from any turbid cultures are diluted
1:10,000 fold. Once all samples are processed, the sample set is analyzed through the qPCR readout portion of the assay. These samples are also
analyzed using the appropriate gene-specific qPCR assay as a comparison. The MIC as determined by the molecular AST analyses were compared
to the MIC as determined from the predicate macrobroth analysis to determine the agreement between these methods.
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binding site for a subsequent qPCR detection reaction.
Thus, DNA polymerase extension activity enables and trig-
gers a downstream qPCR detection reaction. The subse-
quent qPCR detection signal is directly proportional to the
amount of substrate extended, which is proportional of
the amount of microbial DNA polymerase extension ac-
tivity present, and this is proportional to the amount of
viable proliferating bacteria present from culture. Complete
details regarding the ETGA assay have been previously
described [21] a hyperlink is provided [http://nar.oxford
journals.org/content/40/14/e109.full.pdf+html?sid=ea56
a354-4e91-4515-aec8-ccdc5acfb438].
ETGA and gene-specific qPCR analysis of the time course
samples
Stored samples were allowed to thaw at room temperature,
briefly vortexed, and spun down at 12,000×g for one
minute. ETGA readout by qPCR was performed by adding
4 μL of each sample into a reaction well containing
27.2 μL of qPCR reaction mix which has been previously
described [21].
For the parallel-run of corresponding gsPCR for either
S. aureus or E. coli samples, single reactions were run
composed of 3 μL bead mill lysate added to 28 μL of the
appropriate qPCR reaction mix into a reaction well. The
gene targets for the S. aureus and E. coli-specific qPCR
assays are nuc and uidA respectively. The primer and
probe sequences for these assays have been previ-
ously reported [21]. All qPCR analysis was performed
on a Roche LightCycler 480 II system (Roche Applied
Science, Indianapolis, IN). Cycle values were plotted
against time of incubation. The values produced by the
overnight samples were plotted as the measured Ct minus
10 to account for the 1000-fold dilution compared to the
earlier samples. This assumes that each 10-fold dilutionequates to a 3.33 cycle decrease in signal based on an effi-
cient qPCR reaction.
ETGA AST analysis from bacteria harvested from a BD
BACTEC positive blood culture bottle
Institutional review board approval of our procedure
and consent form was provided by the Essex Institu-
tional Review Board Inc. 121 Main St. Lebanon NJ. Eight
to 10 mL of blood from consenting healthy donors were
collected into a BACTEC Plus + Aerobic/F bottle BD,
Franklin Lakes, NJ). This blood culture was then spiked
with 5 to 50 CFU of either S. aureus (MSSA or MRSA)
or E. coli bacteria. The blood culture bottle was incu-
bated in a BD BACTEC 9050 incubator and grown
until the culture is called positive. Once positive, the
bacteria were harvested with a Serum Separation Tube
(SST) (BD, Franklin Lakes, NJ) as described elsewhere
[19,20]. Briefly, the tube was spun for 10 minutes at
2000×g and the supernatant was removed. A sterile,
rayon-tipped swab applicator (BD, Franklin Lakes, NJ)
was used to harvest the bacteria from the gel layer of
the tube and this was suspended into a 0.9% saline so-
lution. From this point forward, these SST preparations
were handled the same as described for pure cultures,
except time points were only taken at four and six
hours of incubation.
Comparison of molecular AST results to the marcobroth
“gold standard” method results
The macrobroth method results are considered the “gold
standard” results because they are performed based on the
currently accepted method as indicated by CLSI documen-
tation. Differences between the molecular AST results and
the gold standard results are defined as follows: 1) an error
is called minor when the molecular AST indicates suscep-
tibility and the macrobroth AST indicates intermediate
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AST indicates resistance and the macrobroth AST indi-
cates susceptibility, and 3) an error is called very major
when the molecular AST indicates susceptibility and the
macrobroth method indicates resistance [12].
Additional data sets
Additional data sets are provided which detail all the
cycle time data used to produce figure and data found
within this manuscript. The file in which these data
can be found is called Supplemental Data to manu-
script.doc. Within this file is Additional file 1: Table S1
and Additional file 1: Table S2. Additional file 1: Table S1,
ETGA and gsPCR Ct Data of AST Experiments from Pure
Cultures, provides data used for Figures 2, 3, and 4 and
pure culture data in Table 1. Additional file 1: Table S2,
ETGA and gsPCR Ct Data of AST Experiments from Cul-
tures Harvested from Positive Blood Cultures, provides
data for the AST experiments from bacteria harvested
from blood culture found in Table 1.
Results
Molecular AST time course analysis of bacteria from
purified cultures
Methicillin sensitive S. aureus strain ATCC 29213 and
E. coli strain ATCC 25922 are both quality control strains
for the macrobroth method and estimated MICs for
these organisms for the antibiotics tested against them
are indicated by the CLSI protocols and standards [6].Figure 2 Methicllin sensitive Staphylococcus aureus against oxacillin a
dilution standard method is shown on the left (A and D), along with the t
analyses, plotting Ct versus time. Vertical, dashed lines indicate when aliqu
signal strength, the y-axes are inverted to visually demonstrate a rise in sigThe ranges of antibiotic concentrations that were tested
are based upon these published values. Methicillin resist-
ant S. aureus strain NRS241 has MICs against specific
drugs published on the NARSA website (http://www.
narsa.net) and the concentration range tested was based
upon these values. The time course curves for both
the ETGA and gsPCR molecular analysis is shown in
Figures 2, 3 and 4 and compared to the visual end-point
analysis of the macrobroth dilution method. The data
sets containing the measured Ct values can be found in
Additional file 1: Table S1.
The ETGA time course analysis for each antibiotic/
microorganism combination tested demonstrate that in
growth control cultures which contain no drug the ETGA
signal increases robustly over time. Depending on the com-
bination tested, however, the rate of change in signal de-
pends on the amount of antibiotic present. For instance,
the MSSA versus oxacillin combination (Figure 2B) shows
that there is an increase in signal in the early time points
out to 2 μg/mL, but the 22 hour time point only the 0
and 0.125 μg/mL cultures demonstrate a continuous in-
crease in signal. At 22 hours, the curves actually indicate
a decrease in signal from 0.25 to 8 μg/mL. These results
correlate with the macrobroth results (Figure 2A), in
which turbidity is seen only in the 0 and 0.125 μg/mL
cultures. Using the gsPCR assay, the signals from all cul-
tures increase over time (Figure 2C), although the rate
slows as the concentration of antibiotic increases. The
MSSA versus vancomycin time course analysis indicatesnd vancomycin AST results. The visual results of the macrobroth
ime course results of the ETGA (B and E) and gsPCR (C and F) AST
ots were removed for analysis. Since Ct values are inversely related to
nal over time.
Figure 3 Methicillin resistant Staphylococcus aureus against oxacillin and vancomycin AST results. The visual results of the macrobroth
dilution standard method is shown on the left (A and D), along with the time course results of the ETGA (B and E) and gsPCR (C and F) AST
analyses, plotting Ct versus time. Vertical, dashed lines indicate when aliquots were removed for analysis. Since Ct values are inversely related to
signal strength, the y-axes are inverted to visually demonstrate a rise in signal over time.
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trol exhibits any increase in signal over time for either the
ETGA or gsPCR assay. The vancomycin macrobroth dilu-
tion results are in agreement with the time course results
(Figure 2D-2F).Figure 4 E. coli against ciprofloxacin and tetracycline AST results. The
on the left (A and D), along with the time course results of the ETGA (B a
Vertical, dashed lines indicate when aliquots were removed for analysis. Sin
inverted to visually demonstrate a rise in signal over time.The ETGA time course for MRSA versus oxacillin dem-
onstrates an increase of signal over time out to 8 μg/mL,
although the rate of growth appears to slow at 8 g/mL
(Figure 3B). The macrobroth dilution results are in agree-
ment with the ETGA curves, since turbidity is seen in allvisual results of the macrobroth dilution standard method is shown
nd E) and gsPCR (C and F) AST analyses, plotting Ct versus time.
ce Ct values are inversely related to signal strength, the y-axes are
Table 1 Comparison of minimum inhibitory concentration results for MSSA, MRSA and E. coli strains
S. aureus ATCC 29213
Bacteria from purified cultures Bacteria harvested from a positive blood culture
bottle








4 hr 6 hr 22 hr 4 hr 6 hr 22 hr 4 hr 6 hr 4 hr 6 hr
Oxacillin Susceptible S ≤ 2 R≥ 4 0.25 S 1 S 0.5 S 0.5 S 0.5 S 1 S 1 S 0.25 S 0.25 S 0.25 S 0.25 S
Vancomycin Susceptible S ≤ 2 I = 4-8 R≥ 16 < 0.25 S <0.25 S <0.25 S <0.25 S <0.25 S <0.25 S <0.25 S <0.125 S <0.125 S <0.125 S <0.125 S
S. aureus NRS241
Bacteria from purified cultures Bacteria harvested from a positive blood culture
bottle








4 hr 6 hr 22 hr 4 hr 6 hr 22 hr 4 hr 6 hr 4 hr 6 hr
Oxacillin Resistant S ≤ 2 R≥ 4 16 R 8 R 16 R > 16 R N/Aa 16 R >16 R 8 R 16 R 8 R 2 Sc (VME)
Vancomycin Susceptible S ≤ 2 I = 4-8 R≥ 16 < 0.25 S <0.25 S <0.25 S <0.25 S <0.25 S <0.25 S <0.25 S <0.25b S <0.25 S <0.25d S <0.25d S
E. coli ATCC 25922
Bacteria from purified cultures Bacteria harvested from a positive blood culture
bottle








4 hr 6 hr 22 hr 4 hr 6 hr 22 hr 4 hr 6 hr 4 hr 6 hr
Ciprofloxacin Susceptible S ≤ 1 I = 2 R≥ 4 0.008 S 0.016 S 0.016 S 0.031 S 0.016 S 0.016 S 0.031 S 0.008 S 0.008 S 0.004 S 0.008 S
Tetracycline Susceptible S ≤ 4 I = 8 R≥ 16 1 S 0.5 S 0.5 S 1 S 1 S 1 S 1 S 0.5 S 0.5 S 0.25 S 0.5 S
All MIC values are in units of μg/mL. Interpretation of MIC values are S susceptible, I intermediate resistance, and R resistant. MICs are determined from the molecular assays as the culture with the lowest
concentration of drug that produces a difference in Ct value that remains less than 3.33 cycles between its Ct value and the Ct value of the culture with the highest concentration of drug, where growth is fully
inhibited. Four discrepancies are noted: aAt 4 hours, the MIC value of the gsPCR method of MRSA versus oxacillin could not be determined since the difference in Ct values moved above and below the cut-off value
between several concentrations. bAt 4 hours, the MIC value of <0.25 μg/mL from the ETGA method of MRSA harvested from blood culture versus vancomycin is interpreted as susceptible and is in agreement with the
macrobroth method. However, the 16 μg/mL culture from the AST series produced a Ct value that indicates resistance. cAt 6 hours, the MIC value of the gsPCR method of MRSA harvested from blood culture versus
oxacilin is interpreted as susceptible, while the macrobroth method MIC is interpreted as resistant. This is defined as a very major error (VME). dThe gsPCR results from the MRSA harvested from blood culture versus
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and 32 μg/mL tend to remain flat. Similar growth kinetics
is observed using the gsPCR assay (Figure 3C), although
the curves for all the concentrations trend upward. Iden-
tical to the MSSA versus vancomycin curves, no MRSA
cultures other than the growth control displays tur-
bidity or an increase of signal over time using either assay
(Figure 3D-F).
The E. coli versus ciprofloxacin ETGA time course
curves demonstrate growth from 0 to 0.004 μg/mL, with
slower growth at 0.004 μg/mL (Figure 4B). Higher drug
concentrations produce flat curves. This result is in
full agreement with the macrobroth dilution results and
the gsPCR growth curve results (Figure 4A and 4C).
Against tetracycline, E. coli displays a robust ETGA
signal increase over time out to 0.5 μg/mL (Figure 4E).
The macrobroth results agree with the ETGA results by
showing turbidity up to 0.5 μg/mL (Figure 4D). At
1 μg/mL and above, the cultures are clear. The time course
analysis using the gsPCR assay is in agreement with both
the ETGA time course results and the macrobroth results
(Figure 4F).
Molecular AST MIC determination of bacteria from
purified cultures
Using the data collected from these time course analyses,
the MIC for each antibiotic/microorganism combination
was determined at 4, 6, and 22 hours, using both ETGA
and gsPCR data. Each MIC was determined by comparing
the difference in Ct between the culture with the highest
concentration of antibiotic to each of the other cultures in
the series. A difference in Ct of 3.33 or more (a 1 log differ-
ence in signal) indicates a reliable increase in signal and
the culture is considered to be actively proliferating. There-
fore, the lowest concentration of drug in which the differ-
ence in Ct value remains less than 3.33 cycles is called the
MIC for that series.
The molecular MICs for each series were deter-
mined and compared to the macrobroth method as
shown in Table 1. While the ETGA-determined MIC
may differ by one or two-fold concentrations away from
the macrobroth MIC, all series produced an ETGA MIC
that was in agreement with the expected CLSI interpret-
ation. This was the case at all time points. Similar results
were obtained with gsPCR method, except at the 4 hour
time point of the MRSA versus oxacillin series (Table 1,
superscript a). At this time point the signal moved both
above and below the 3.33 cycle breakpoint at several dilu-
tions of drug, and a MIC was unable to be determined.
These results provide evidence that ETGA can be used to
generate a reliable MIC for AST analysis by as much as
16 hours sooner than traditional AST methods, and func-
tions in a similar fashion to molecular AST analysis using
gsPCR assays.Molecular AST MIC determination of bacteria from
positive blood cultures
Beuving and colleagues [19,20] have demonstrated that
molecular AST can be performed on bacteria harvested
directly from positive blood cultures by collecting the
microbes from the culture using a SST. Such a method
could produce a reliable MIC for a series of antibiotics
against a pathogenic microbe without the need for its
isolation, thereby further reducing the time required to
obtain a reliable result. The same methodology was ap-
plied to the following ETGA experiments. Blood cultures
were spiked with MSSA, MRSA, or E. coli, allowed to be
called positive in a BACTEC 9050 incubator, the bacteria
were harvested with an SST, and molecular AST was
performed as previously described in the materials and
methods.
The results and comparison of the molecular analyses
to the macrobroth dilution method are shown in Table 1
and Additional file 1: Table S2. Analysis was carried out
as before using both molecular methods at the four and
six hour incubation time points. ETGA analysis pro-
duced MIC values that were mostly in agreement with
the macrobroth method and correlated with the CLSI
interpretation. However, one discrepancy (Table 1, foot-
note b) was observed at the four hour time point of the
MRSA versus vancomycin series. While the MIC was de-
termined to be less than 0.25 μg/mL, the 16 μg/mL culture,
produced a signal with a Ct value greater than 3.33 cycles
above the baseline. This isolated result was neither sup-
ported by the results from the other cultures in the series,
its paired gsPCR reactions, nor the results from the six
hour time point. The result is most likely indicative of an
operator error. Such a result can occur when performing
standard AST dilution methods. CLSI and similar AST
protocols provide guidelines for interpreting such results
and repeating the testing, if necessary [6,7].
The gsPCR analysis produced similar results to the
ETGA analysis (Table 1) with two important discrepancies
that require attention. The first is MRSA versus oxacillin at
the six hour time point (Table 1, superscript c). Using the
gsPCR method, the MIC was called at 2 μg/mL. Based on
CLSI interpretation, this MIC value represents a suscep-
tible phenotype. The expected phenotype, however, is re-
sistant, and this is verified by the macrobroth method, the
ETGA method at four and six hours, and the gsPCR
method at 4 hours. This result is considered to be a very
major error, since the molecular result indicates suscepti-
bility, but the predicate method indicates resistance. The
difference in Ct value between the 32 μg/mL culture and
2 μg/mL culture is just below the 3.33 cycle cut-off. Had
the MIC been called at 4 μg/mL, the result would have
been in agreement.
The second discrepancy produced by the gsPCR
method was in the series of MRSA versus Vancomycin
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produced a negative result, particularly at the zero hour
time point. The baseline was accounted for by giving an
arbitrary Ct value to each of these reactions of 38, the
approximate cycle time a single copy of gene target is
detected by qPCR. Once the baseline was adjusted reli-
able results were obtained. When either sensitive or
resistant S. aureus was harvested from the blood cul-
ture using the SST, the inoculation verification pro-
duced CFU counts that were too low to be enumerable.
Unlike the gsPCR assay, the ETGA assay detected the pres-
ence of bacteria in the cultures at the zero hour time point
(Additional file 1: Table S1 and Additional file 1: Table S2).
Discussion and conclusions
This report describes preliminary data for the use of
ETGA as a rapid molecular method for producing reli-
able AST results. The results demonstrate that aliquots
of cultures in a two-fold dilution series of antibiotic can
be removed and analyzed with ETGA to determine a
MIC much sooner than visual endpoint analysis that re-
quires an overnight incubation of the cultures. The re-
sults of ETGA AST also correlate well with molecular
AST results using gsPCR assays.
Recent literature describes molecular AST methods
that employ qPCR assays which amplify the rpoB gene
of the 16S rDNA locus of the bacterial genome as the
marker for bacterial proliferation in culture [16,19,20].
The rDNA region is used as a universal gene target be-
cause the region is well conserved across prokaryotes
and therefore only a single assay need be designed and
validated. While the frequency of organisms that cause
bacteremia has been fairly well defined [23] the list is by
no means exhaustive. These studies shows genuine prom-
ise for the use of molecular AST as a method for achieving
more rapid time to results, but the rpoB locus as a gene
target may also create limitations. The rDNA region still
exhibits considerable sequence variations across species,
and degenerate primers and probes are required in order
to detect a wide range of microorganisms [24-26]. Univer-
sal rDNA primers, no matter how well designed and vali-
dated, are not be able to amplify every possible organism
or do so with equal efficiency.
Contrary to existing ‘universal’ PCR methodologies,
ETGA is a highly sensitive enzymatic assay, not a genetic
assay. Instead of genomic DNA, ETGA monitors bacterial
proliferation in culture via measurement of endogenous
DNA polymerase extension activity. Due to the highly con-
served biochemical activity of DNA polymerase, the ETGA
approach is not constrained to limitations in gene se-
quence based assays.
The ETGA AST method was successful in producing
MICs that were in agreement with results obtained from
the macrobroth dilution method using bacteria harvesteddirectly from positive blood cultures. In contrast, gsPCR
was less successful: MRSA versus oxacillin produced a very
major error at six hours, and MRSA versus vancomycin
produced gsPCR reactions that were not always detected.
A point of concern with these experiments is that the in-
oculation verification indicated that the bacterial input was
much lower than 5E + 05 CFU/mL because the CFU
were too dilute to be countable. It has been reported that
a 0.5 McFarland standard, which is expected to be within
1-2E + 08 CFU/mL may be as low as 1E + 07 CFU/mL
depending on the species being measured [3]. While this
lower titer appeared not to affect the macrobroth or the
ETGA results, it may have affected the gsPCR results.
The procedure for harvesting the bacteria with a SST
was followed as described by Beuving et al. [19,20]. How-
ever, their manuscripts do not indicate whether the investi-
gators verified their inoculation concentration performing
their molecular AST assays. Harvesting bacteria with SST
from positive blood cultures was previously described by
Funke and Funke-Kissling [13] for gram negative rods, and
by Lupetti et al. [14] for gram positive cocci. In these re-
ports, gram negative rods were harvested by applying posi-
tive blood culture directly into an SST, but gram positive
cocci were first incubated in a 0.01% final concentration of
saponin. The report from Beuving et al. harvests bacteria
through an SST without any pre-treatment regardless of
the gram status. If pre-treatment of the blood culture be-
fore serum separation is required for a more efficient bac-
terial yield, particularly for gram positive cocci, this could
be a reason for some of the errors that we observed. Fur-
thermore, we noticed that transferring bacteria from the
gel plug to the saline solution can also lead to transferring
some of the gel which could lead to overestimating the
turbidity of the 0.5 McFarland standard. This observation
presents an opportunity to further improve the sample
preparation for increased bacterial yield harvested directly
from positive blood cultures and ultimately improve the
accuracy of molecular AST.
Wiegard et al. [7] describe a microdilution AST method
performed in a 96-well microtiter plate. The authors
present a protocol in which a bacterium of interest is inoc-
ulated into a matrix of various antibiotics and concentra-
tions. This plate is incubated for 16–20 hours prior to
interpreting the results by visual observation. Utilizing this
design, a high-throughput ETGA AST method could be
developed. In this scenario, an AST matrix can be assem-
bled (keeping a few wells available for the required ETGA
controls), and allowed to incubate for four to six hours. At
a single time point, samples could be removed using a
multi-channel pipette and diluted in water in a second
micro-titer plate maintaining the same matrix pattern.
After dilution, samples could then be transferred to a third
micro-titer plate containing the ETGA reaction mix
and glass beads. There are several 96-well format sample
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lized to vortex the plate. After milling the plate would
then be incubated at 37°C to enable substrate conversion.
The samples could then be transferred to a final PCR
microwell plate containing the ETGA qPCR reagents for
the readout on a real-time PCR thermocylcer. The ori-
ginal AST plate could be returned to the incubator to
produce an overnight result for verification purposes, if
desired. Throughput could be further increased and error
rate further reduced by designing a robotic system for
the workflow.
This report has demonstrated that ETGA-mediated
monitoring of bacterial DNA polymerase activity can be
used to perform molecular AST and produce a reliable
susceptibility interpretation that is equivalent to the
CLSI macrodilution method in approximately 6 hours
instead of 20–24 hours. This method has an advantage
over PCR-based molecular AST that uses a gene target
as the analyte because it is more universal in nature.
These results suggest that it is possible to perform ETGA
AST on bacteria harvested directly from blood culture
without the need for extensive isolation and subculture,
further reducing the time to results. In future experi-
ments, ETGA AST will be validated against a wider array
of pathogenic microbes and antimicrobial agents. This
will be done on both bacterial isolates and directly from
clinical culture samples. Further development of ETGA
AST as a method that can be used in a clinical laboratory
setting is ongoing.Additional file
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ETGA and gsPCR Ct data of AST experiments from cultures harvested from
positive blood cultures. Values in bold indicate the concentration in which
the MIC was called. Values in red indicate discrepancies in the results.Competing interest
Bruce Sodowich, Daniel Zweitzig, Nichol Riccardello, and S. Mark O’Hara are all
employees of Zeus Scientific Incorporated, a medical diagnostics company.
Authors’ contributions
BS designed and executed experiments, and drafted the manuscript. DZ
provided technical and critical review of the experimental design and results,
and edited the manuscript. NR provided necessary laboratory support and
repeated experimentation as necessary. SOH is the group leader and
principal investigator. All authors read and approved the final manuscript.
Acknowledgements
Methicillin resistant Staphylococcus aureus strain NRS241 was provided by the
Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA). We
thank Mark Kopnitsky for his guidance and review of the manuscript and
ZEUS Scientific for its funding of this project.
Received: 5 February 2013 Accepted: 25 July 2013
Published: 13 August 2013References
1. Wheat PF: History and development of antimicrobial susceptibility
testing methodology. J Antimicrob Chemother 2001, 48(Suppl. S1):104.
2. Holland TL, Woods CW: Antibacterial susceptibility testing in the clinical
laboratory. Infect Dis Clin N Am 2009, 23:757–790.
3. Andrews JM: Determination of minimum inhibitory concentrations.
J Antimicrob Chemother 2001, 48(Suppl. S1):5–16.
4. Clinical Laboratory and Standards Institute: Performance standards for
antimicrobial disk susceptibility tests; approved standard – eleventh edition,
CLSI document M02-A11 Vol. 32 No. 1. Wayne PA, USA: Clinical Laboratory
and Standards Institute; 2012.
5. Andrews JM: BSAC standardized disc susceptibility testing method
(version 5). J Antimicrob Chemother 2006, 58:511–529.
6. Clinical Laboratory and Standards Institute: Methods for dilution antimicrobial
susceptibility tests for bacteria that grow aerobically; approved standard –
eighth edition, CLSI document M07-A9 Vol. 32 No. 2. Wayne PA, USA: Clinical
Laboratory and Standards Institute; 2012.
7. Wiegand I, Hilpert K, Hancock REW: Agar and broth dilution methods to
determine the minimal inhibitory concentration (MIC) of antimicrobial
substances. Nat Protoc 2008, 3(2):163–175.
8. Clinical Laboratory and Standards Institute: Performance standards for
antimicrobial susceptibility testing; twenty-third informational supplement CLSI
document, M100-23 Vol. 33 No. 1. Wayne PA, USA: Clinical Laboratory and
Standards Institute; 2013.
9. Tenover FC: Potential impact of rapid diagnostic tests on improving
antimicrobial use. Ann NY Acad Sci 2010, 1213:70–80.
10. Barenfanger J, Drake C, Kacich K: Clincal and financial benefits of rapid
bacterial identification and antimicrobial susceptibility testing. J Clin
Microbiol 1999, 37(5):1415–1418.
11. Doern GV, Vautour R, Gaudet M, Levy B: Clinical impact of rapid in vitro
susceptibility testing and bacterial identification. J Clin Microbiol 1994,
32(7):1757–1762.
12. Jorgensen JH: Selection criteria for an antimicrobial susceptibility testing
system. J Clin Microbiol 1993, 31(11):2841–2844.
13. Funke G, Funke-Kissling P: Use of the BD PHOENIX automated
microbiology system for direct identification and susceptibility testing of
gram-negative rods from positive blood cultures in a three-phase trial.
J Clin Microbiol 2004, 42(4):1466–1470.
14. Lupetti A, Barnini S, Castagna B, Nibbering PH, Campa M: Rapid identification
and antimicrobial susceptibility testing for gram-positive cocci in blood
cultures by direct inoculation into the BD pheonix system. Clin Microbiol Infect
2009, 16(7):986–991.
15. Noman F, Jehan A, Ahmed A: Reliability of direct sensitivity determination
of blood cultures. J Coll Physicians Surg Pak 2008, 18(10):660–661.
16. Rolain JM, Mallet NM, Fournier PE, Rauolt D: Real-time PCR for
universal antibiotic susceptibility testing. J Antimicrol Chemother
2004, 54:528–541.
17. Hunfeld KP, Bittner T, Rödel R, Brade V, Cinatl J: New real-time PCR-
based method for in vitro susceptibility testing of anaplasma
phagocytophilum against antimicrobial agents. Int J Antimicrob Agents
2004, 23(6):563–571.
18. Waldeisen JR, Wang T, Debksihore M, Lee LP: A real-time PCR antibiogram
for drug-resistant sepsis. PLoS One 2001, 6(12):e28528.
19. Beuving J, Verbon A, Gronthoud FA, Stobberingh EE, Wolffs PFG:
Antiobiotic susceptibility testing of grown blood cultures by combining
culture and real-time polymerase chain reaction is rapid and effective.
PLoS One 2011, 6(12):e27689.
20. Hansen WL, Beuving J, Verbon A, Wolffs PF: One-day workflow scheme for
bacterail pathogen detection and antimicrobial resistance testing from
blood cultures. J Vis Exp 2012, 65:e3254. doi:10.3791/3254.
21. Zweitzig DR, Riccardello NM, Sodowich BI, O’Hara SM: Characterization
of a novel DNA polymerase activity assay enabling sensitive and
universal detection of viable microbes. Nuc Acids Res 2012,
40(14):e109.
22. Chambers HF, Hackbarth CJ: Effect of NaCl and nafcillin on penicillin-
binding protein 2a and heterogeneous expression of methicillin
resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1987,
31(12):1982–1988.
23. Ecker DJ, Sampath R, Li H, Massire C, Mattews HE, et al: New technology for
rapid molecular diagnosis of bloodstream infections. Expert Rev Mol
Diagn 2010, 10(4):399–415.
Sodowich et al. BMC Microbiology 2013, 13:191 Page 10 of 10
http://www.biomedcentral.com/1471-2180/13/19124. Forney LJ, Zhou X, Brown CJ: Molecular microbial ecology: land of the
one-eyed king. Curr Opin Microbiol 2004, 7:210–220.
25. Baker GC, Smith JJ, Cowan DA: Review and re-analysis of domain-specific
16S primers. J Microbiol Methods 2003, 55:541–555.
26. Janda JM, Sl A: 16s RRNA gene sequencing for bacterial identification in
the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol 2007,
45:2761–2764.
doi:10.1186/1471-2180-13-191
Cite this article as: Sodowich et al.: Feasibility study demonstrating that
enzymatic template generation and amplification can be employed as a
novel method for molecular antimicrobial susceptibility testing. BMC
Microbiology 2013 13:191.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
